Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Vical licenses gene delivery technology to RPR

Oct. 9, 1997

PowderJect and Boehringer Mannheim agreement for protein delivery

Oct. 8, 1997

Aastrom Biosciences awarded two NIH grants; begins phase I trial of UCB transplants

Oct. 8, 1997

Cell Genesys reports development of second-generation lentiviral gene delivery system

Oct. 8, 1997

NIH contemplates licensing liposomal delivery technology to Biovector Therapeutics

Oct. 7, 1997

Sequana receives Phase I SBIR grant for RAMMP technology

Oct. 7, 1997

SDD drug delivery system available for licensing from Bioglan

Oct. 6, 1997

Genetronics receives NCI grant for electroporation research

Oct. 2, 1997

Allergan and Acadia enter drug discovery collaboration

Sep. 29, 1997

Baxter and Inhale commence phase II trial using pulmonary delivery system

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...